Pediatrix Medical Group, Inc.

Historical 13F Holders

Symbol
MD
CUSIP
58502B106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 58502B106 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 14.6% 7/17/2025
Event 6/30/2025
Vanguard Portfolio Management LLC 13G 7.6% 9/3/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.2% 9/3/2026
Event 3/31/2026
Dimensional Fund Advisors LP 13G 5.1% 7/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Rubric Capital Management LP 13G/A
3.7% 2/13/2025
Event 12/31/2024
AllianceBernstein L.P. 13G/A 2.2% 6/3/2025
Event 5/31/2025
Vanguard Group Inc 13G/A 0% 9/3/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 6 5.96 k $153 k
2026 Q2 310 86.9 M $2.25 B
2026 Q1 299 83.1 M $1.78 B
2025 Q4 306 84.2 M $1.80 B
2025 Q3 276 81.4 M $1.36 B
2025 Q2 271 82.2 M $1.18 B
2025 Q1 251 80.2 M $1.16 B
2024 Q4 237 82.3 M $1.08 B
2024 Q3 225 86.9 M $1.01 B
2024 Q2 237 92.1 M $695 M
2024 Q1 225 90.0 M $903 M
2023 Q4 235 84.2 M $783 M
2023 Q3 214 82.0 M $1.04 B
2023 Q2 224 82.1 M $1.16 B
2023 Q1 223 83.8 M $1.25 B
2022 Q4 223 87.9 M $1.31 B
2022 Q3 222 84.3 M $1.39 B
2022 Q2 209 86.6 M $1.82 B
2022 Q1 232 84.6 M $1.99 B
2021 Q4 214 83.9 M $2.29 B
2021 Q3 231 84.8 M $2.41 B
2021 Q2 233 88.7 M $2.67 B
2021 Q1 217 90.9 M $2.32 B
2020 Q4 220 96.5 M $2.37 B
2020 Q3 220 83.5 M $1.36 B
2020 Q2 231 86.0 M $1.47 B
2020 Q1 238 83.2 M $969 M
2019 Q4 269 79.5 M $2.21 B
2019 Q3 233 78.9 M $1.78 B
2019 Q2 269 79.3 M $2.00 B
2019 Q1 310 80.8 M $2.20 B
2018 Q4 319 88.1 M $2.91 B
2018 Q3 337 92.5 M $4.31 B
2018 Q2 340 91.4 M $3.95 B
2018 Q1 361 92.1 M $5.12 B
2017 Q4 350 93.7 M $5.00 B
2017 Q3 351 92.8 M $4.00 B
2017 Q2 348 94.9 M $5.73 B
2017 Q1 371 102 M $7.10 B
2016 Q4 403 101 M $6.76 B
2016 Q3 396 94.8 M $6.28 B
2016 Q2 405 95.2 M $6.89 B
2016 Q1 399 92.3 M $6.09 B
2015 Q4 417 96.6 M $6.92 B
2015 Q3 390 92.8 M $7.12 B
2015 Q2 362 97.2 M $7.20 B
2015 Q1 360 95.4 M $7.18 B
2014 Q4 343 98.7 M $6.77 B
2014 Q3 347 102 M $5.70 B
2014 Q2 347 105 M $6.11 B
2014 Q1 327 100 M $6.23 B